MedPath

Cutia Therapeutics (Shanghai) Co., Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2021-07-14
Last Posted Date
2023-09-28
Lead Sponsor
Cutia Therapeutics (Shanghai) Co., Ltd
Target Recruit Count
372
Registration Number
NCT04960930
Locations
🇨🇳

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

China-Japan Friendship Hospital, Beijin, Beijin, China

🇨🇳

Dermatology Hosptial of Southern Medical University, Yuexiu, Guangdong, China

and more 26 locations
© Copyright 2025. All Rights Reserved by MedPath